Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Annovis BioANVS | Open-market buy | 05/20 | 05/21 | 76,344 sh3 trades | $1.87avg. | $142,784.4 | +2.3% | |
Michael B. HoffmanDirector | Annovis BioANVS | Open-market buy | 04/02 | 04/03 | 713,800 sh | $2.10 | $1,498,980 | +27.7% |
Annovis BioANVS | Open-market buy | 25/12/08 | 25/12/08 | 45,000 sh2 trades | $4.31avg. | $193,800 | +1.8% | |
Annovis BioANVS | Open-market buyAmendment | 25/11/24 | 25/11/25 | 78,400 sh8 trades | $4.08avg. | $319,772.14 | +3.2% | |
Annovis BioANVS | Open-market buy | 25/11/21 | 25/11/21 | 20,000 sh2 trades | $3.50avg. | $69,900 | +0.8% | |
Michael B. HoffmanDirector | Annovis BioANVS | Open-market buy | 25/11/14 | 25/11/18 | 15,000 sh | $2.11 | $31,650 | +0.6% |
Michael B. HoffmanDirector | Annovis BioANVS | Open-market buy | 25/10/28 | 25/11/12 | 975,610 sh | $2.05 | $2,000,000.5 | +65.9% |
Maria-Luisa MaccecchiniPresident & CEO | Annovis BioANVS | Open-market buy | 25/10/28 | 25/11/12 | 97,561 sh | $2.05 | $200,000.05 | +8.8% |